[1]
|
Mannucci, P.M. and Tuddenham, E.G.D. (2001) The Hemophilias—From Royal Genes to Gene Therapy. New England Journal of Medicine, 344, 1773-1779. https://doi.org/10.1056/NEJM200106073442307
|
[2]
|
杨仁池. 中国血友病管理指南(2021年版) [M]. 北京: 中国协和医科大学出版社, 2021.
|
[3]
|
程彦, 房云海, 张心声. 血友病救助体系的现状和探讨[J]. 罕见病研究, 2022, 1(4): 375-379.
|
[4]
|
温红, 郭碧赟. 长期小剂量凝血因子VIII预防重度血友病A患儿关节出血的疗效与相关因素分析[J]. 中国小儿血液与肿瘤杂志, 2013, 18(1): 35-38.
|
[5]
|
Acharya, S.S. (2016) Advances in Hemophilia and the Role of Current and Emerging Prophylaxis. The American Journal of Managed Care, 22, 116-125.
|
[6]
|
Nilsson, I.M., Berntorp, E., Löfqvist, T. and Pettersson, H. (1992) Twenty-Five Years’ Expe-rience of Prophylactic Treatment in Severe Haemophilia A and B. Journal of Internal Medicine, 232, 25-32.
https://doi.org/10.1111/j.1365-2796.1992.tb00546.x
|
[7]
|
Manco-Johnson, M.J., Abshire, T.C., Shapiro, A.D., et al. (2007) Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia. New Eng-land Journal of Medicine, 357, 535-544.
https://doi.org/10.1056/NEJMoa067659
|
[8]
|
Gringeri, A., Lundin, B., Von Mackensen, S., Mantovani, L., Man-nucci, P.M. and ESPRIT Study Group (2011) A Randomized Clinical Trial of Prophylaxis in Children with Hemophilia A (The Esprit Study). Journal of Thrombosis and Haemostasis, 9, 700-710. https://doi.org/10.1111/j.1538-7836.2011.04214.x
|
[9]
|
Berntorp, E. (2013) History of Prophylaxis. Haemophilia, 19, 163-165. https://doi.org/10.1111/hae.12100
|
[10]
|
吴润晖. 中国儿童血友病专家指导意见(2017年) [J]. 中国实用儿科杂志, 2017, 32(1): 11-15.
|
[11]
|
王梦媛, 姚敏, 万丹丹, 等. 187例血友病患儿关节状况与生活质量分析[J]. 浙江医学, 2017, 39(9): 736-739.
|
[12]
|
黄昆, 陈振萍, 吴润晖. 影响血友病A患者FVIII药代动力学参数的相关因素[J]. 血栓与止血学, 2019, 25(5): 897-900.
|
[13]
|
Collins, P.W., Fischer, K., Morfini, M., et al. (2011) Implica-tions of Coagulation Factor VIII and IX Pharmacokinetics in the Prophylactic Treatment of Haemophilia. Haemophilia, 17, 2-10.
https://doi.org/10.1111/j.1365-2516.2010.02370.x
|
[14]
|
Peters, R. and Harris, T. (2018) Advances and Innovations in Haemophilia Treatment. Nature Reviews Drug Discovery, 17, 493-508. https://doi.org/10.1038/nrd.2018.70
|
[15]
|
Pipe, S.W., Montgomery, R.R., Pratt, K.P., Lenting, P.J. and Lillicrap, D. (2016) Life in the Shadow of a Dominant Partner: The FVIII-VWF Association and Its Clinical Implications for Hemo-philia A. Blood, 128, 2007-2016.
https://doi.org/10.1182/blood-2016-04-713289
|
[16]
|
Pestel, S., Beltz, H.W., Claar, P., et al. (2020) FVIII Half-Life Extension by Coadministration of a D’D3 Albumin Fusion Protein in Mice, Rabbits, Rats, and Monkeys. Blood Advanc-es, 4, 1870-1880.
https://doi.org/10.1182/bloodadvances.2019000999
|
[17]
|
Peyvandi, F., Garagiola, I. and Young, G. (2016) The Past and Future of Haemophilia: Diagnosis, Treatments, and Its Complications. Lancet, 388, 187-97. https://doi.org/10.1016/S0140-6736(15)01123-X
|
[18]
|
中华医学会血液学分会血栓与止血学组, 中国血友病协作组. 血友病诊断与治疗中国专家共识(2017年版) [J]. 中华血液学杂志, 2017, 38(5): 364-370.
|
[19]
|
Benson, G., Auerswald, G., Elezović, I., et al. (2012) Immune Tolerance Induction in Patients with Severe Hemophilia with Inhibitors: Expert Panel Views and Recommendations for Clinical Practice. European Journal of Haematology, 88, 371-379. https://doi.org/10.1111/j.1600-0609.2012.01754.x
|
[20]
|
Escuriola Ettingshausen, C. and Sidonio Jr., R.F. (2021) Design of an International Investigator-Initiated Study on Modern Treatment of Inhibitor-Positive Patients with Haemo-philia a (Motivate). Therapeutic Advances in Hematology, 12, Article ID: 20406207211032452. https://doi.org/10.1177/20406207211032452
|
[21]
|
Hay, C.R. and DiMichele, D.M. (2012) The Principal Results of the International Immune Tolerance Study: A Randomized Dose Comparison. Blood, 119, 1335-1344. https://doi.org/10.1182/blood-2011-08-369132
|
[22]
|
Shima, M., Hanabusa, H., Taki, M., et al. (2017) Long-Term Safety and Prophy-Lactic Efficacy of Once-Weekly Subcutaneous Administration ofACE910 in Japanese Hemophilia A Patients with and without FVIII Inhibitors: Interim Results of the Extension Study of a Phase 1 Study. Journal of Thrombosis and Haemostasis, 13, AS017.
|
[23]
|
Nogami, K. (2016) [A Bispecific Antibody Mimicking Factor Viii in Hemophilia a Therapy]. Rinsho Ketsueki, 57, 709-714. (In Japanese)
|
[24]
|
Dunbar, C.E., High, K.A., Joung, J.K., et al. (2018) Gene Therapy Comes of Age. Science, 359, eaan4672.
https://doi.org/10.1126/science.aan4672
|
[25]
|
Poisson, J., Lemoinne, S., Boulanger, C., et al. (2017) Liver Sinusoi-dal Endothelial Cells: Physiology and Role in Liver Diseases. Journal of Hepatology, 66, 212-227. https://doi.org/10.1016/j.jhep.2016.07.009
|
[26]
|
Dimichele, D., Miller, F.G. and Fins, J.J. (2003) Gene Therapy Ethics and Haemophilia: An Inevitable Therapeutic Future? Haemophilia, 9, 145-152. https://doi.org/10.1046/j.1365-2516.2003.00725.x
|
[27]
|
UK Haemophilia Centre Doctors’ Organisation Working Party (2004) Gene Therapy Trials in the Uk: Is Haemophilia a Suitable ‘Model’? Clinical Medicine Journal, 4, 54-56. https://doi.org/10.7861/clinmedicine.4-1-54
|
[28]
|
Shirley, J.L., de Jong, Y.P., Terhorst, C. and Herzog, R.W. (2020) Immune Responses to Viral Gene Therapy Vectors. Molecular Therapy, 28, 709-722. https://doi.org/10.1016/j.ymthe.2020.01.001
|
[29]
|
Colella, P., Ronzitti, G. and Mingozzi, F. (2018) Emerging Issues in AAV-Mediated in Vivo Gene Therapy. Methods & Clinical Development, 8, 87-104. https://doi.org/10.1016/j.omtm.2017.11.007
|
[30]
|
George, L.A., Monahan, P.E., Eyster, M.E., et al. (2021) Multi-year Factor VIII Expression after AAV Gene Transfer for Hemophilia A. New England Journal of Medicine, 385, 1961-1973. https://doi.org/10.1056/NEJMoa2104205
|
[31]
|
刘国青, 王海红, 吴润晖, 等. 血友病的家庭治疗[J]. 血栓与止血学, 2015, 21(5): 326-327, 333.
|
[32]
|
Smith, P.S. and Levine, P.H. (1984) The Benefits of Comprehensive Care of Hemophilia: A Five-Year Study of Outcomes. American Journal of Public Health, 74, 616-617. https://doi.org/10.2105/AJPH.74.6.616
|
[33]
|
Mahony, B.O., Savini, L., Hara, J.O. and Bok, A. (2017) Haemophilia Care in Europe—A Survey of 37 Countries. Haemophilia, 14, 216-224. https://doi.org/10.1111/hae.13263
|
[34]
|
吴心怡, 王旭梅, 甄英姿, 王春立, 张娴. 儿童血友病家庭治疗开展现状调查[J]. 护理研究, 2016, 30(33): 4192-4195.
|
[35]
|
孟莎, 刘民. 将艾滋病/性病预防服务纳入城市社区卫生服务案例研究[J]. 中国全科医学, 2009, 12(11): 1037-1038.
|
[36]
|
Evatt, B.L., Black, C., Batorova, A., Street, A. and Srivastava, A. (2004) Comprehensive Care for Haemophilia around the World. Haemophilia, 10, 9-13. https://doi.org/10.1111/j.1365-2516.2004.01010.x
|